[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
作者信息
Kamianov I M, Kupisk A G, Katsen I Z
出版信息
Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(8):1218-23.
PMID:4149581
Abstract
摘要
相似文献
1
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(8):1218-23.
2
[Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1974;74(8):1178-81.
3
[Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
Encephale. 1972 Jan-Feb;61(1):32-52.
4
Neutralization of extrapyramidal side-effects with Methixene.
Dis Nerv Syst. 1971 Jun;32(6):409-15.
5
The antiparkinson properties of amantadine in drug-induced parkinsonism.
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):211-4.
6
Drug-induced extrapyramidal syndromes.
J R Coll Physicians Lond. 1970 Oct;5(1):87-98.
7
[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(3):453-7.
8
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1969;69(12):1862-8.
9
The extrapyramidal neuroleptic syndrome: description and measurement.
Curr Ther Res Clin Exp. 1973 Jul;15(7):427-40.
10
Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
Curr Ther Res Clin Exp. 1972 May;14(5):246-51.
Zotero 插件